Company news
Viaderma, Inc. (OTC:VDRM) news
Viaderma, Inc. news releases on 6ix. Latest, Apr 19, 2017: ViaDerma, Inc. Announces its President, Dr. Christopher Otiko's Abstract was Well Received…
Press releases — page 2
ViaDerma, Inc. Announces its President, Dr. Christopher Otiko's Abstract was Well Received at the DFCON Conference as the Company Completes Final Testing for its FDA Registered Viabecline for Manufacturing in the Next Several Weeks
April 19, 2017
ViaDerma Receives Provisional Patent Numbers for Its FDA Registered Viabecline and Cannabis Technologies, and Seeks to Distribute its Products with a Management, Marketing and Distribution Company in Canada to Approved International Cannabis Countries
March 20, 2017
ViaDerma, Inc. Hires Product Rollout Expert to Manage Quality Control Labeling, Marketing and Distribution of its Go to Market Product Line Launch
March 8, 2017
ViaDerma, Inc. Looks to File Additional Patents & License New Products for its (MMJ) Medical Marijuana Patent Pending Delivery Technology with Licensed Dispensaries
February 15, 2017
Dr. Chris Ayo Otiko, President of ViaDerma, Inc., is selected to write an article "Healing Diabetic Ulcers with a New Topical Antibiotic Ointment" for the Journal of Diabetes Science and Technology, a leading US Publication for Diabetes
February 8, 2017
ViaDerma, Inc. Targets Online Sales, Wound Care Centers and Distribution Companies for its Viabecline Product Launch, the First Viabecline Orders Set for Q2-2017, also Onychomycosis Clinical Studies Show Significant Results
February 3, 2017
ViaDerma, Inc's CEO Files New Patent Application, Signs Two Licensing Deals, Locates Product Manufacturers in the US & Abroad, and Plans to add over 500 Affiliates Selling Viabecline Through Established Online Distribution Networks in 2017
January 11, 2017
ViaDerma, Inc. Clinical Studies Abroad in Europe, the Middle East and Asia Show Promising Results & Leads to Private Label Discussions
November 30, 2016
ViaDerma, Inc. Enters the (MMJ) or Medical Marijuana industry with a Patent Pending CBD Delivery System as California Votes for Expanded Uses of Cannabis
November 14, 2016
ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis
March 2, 2015
ViaDerma, Inc. Announces Preston Richards to Join Advisory Board
January 22, 2015
ViaDerma, Inc. Launches New Website
January 13, 2015
TetraStem(TM) Antibiotic Continues to Demonstrate Treatment Success Leading Management to Explore Partnerships With Big Pharmaceutical Companies
December 9, 2014
ViaDerma, Inc. Lead Product TetraStem Shows Promise in Treating Acne
November 21, 2014
ViaDerma, Inc. Appoints Dr. Andrew Berman as Medical Director of Advisory Board
November 13, 2014
TetraStem, Lead Product of ViaDerma, Inc., Hopes to Slow Rates of Diabetic Amputations
November 7, 2014
ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA
October 30, 2014
ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015
October 29, 2014
ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group
August 5, 2014